Clinical Trial Update: CAPTURER PMCF Study ( rEPIC04D )

View source ↗

Summary

CAPTURER PMCF Study (rEPIC04D), sponsored by Fundación EPIC, has completed its post-market clinical follow-up in patients with coronary artery disease and ische…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Snippet

Sponsor: Fundación EPIC | Conditions: Coronary Artery Disease (CAD), Ischemic Heart Disease | Status: COMPLETED